Ertapenem Associated With Seizures in Treatment of Pyelonephritis in a Chronic Peritoneal Dialysis Patient

Ther Apher Dial. 2016 Feb;20(1):89-90. doi: 10.1111/1744-9987.12334. Epub 2015 Dec 29.

Authors

Fatih Yılmaz¹, Himmet Uslu², Fevzi Ersoy³

Affiliations

¹ Department of Internal Medicine, Erzurum Training and Research Hospital, Erzurum. fthylmz79@gmail.com.
² Van Training and Research Hospital, Van.
³ Division of Nephrology, Department of Medicine, Akdeniz University Medical School, Antalya, Turkey.

PMID: 26710680
DOI: 10.1111/1744-9987.12334

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Intravenous
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / adverse effects
Drug Dosage Calculations
Ertapenem
Escherichia coli / isolation & purification
Humans
Kidney Failure, Chronic* / complications
Kidney Failure, Chronic* / therapy
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory / methods
Pyelonephritis / diagnosis
Pyelonephritis / drug therapy*
Pyelonephritis / etiology
Pyelonephritis / physiopathology
Seizures* / chemically induced
Seizures* / prevention & control
beta-Lactams* / administration & dosage
beta-Lactams* / adverse effects

Substances

Anti-Bacterial Agents
beta-Lactams
Ertapenem